QuidelOrtho (QDEL)

• Market cap: $2.72B
• 1 day: -1.39%
• 5 days: -3.78%
• 1 month: -7.46%
• 3 months: 6.78%
• 6 months: -6.69%
• Year to date: -10.17%
• 1 year: -18.23%
• 5 years: -49.04%
• 10 years: 61.78%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

About: QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Employees: 7,100

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

48% more repeat investments, than reductions

Existing positions increased: 108 | Existing positions reduced: 73

29% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 42

3% more funds holding

Funds holding: 259 [Q3] → 267 (+8) [Q4]

8% more call options, than puts

Call options by funds: $13.9M | Put options by funds: $12.9M

0.77% more ownership

Funds ownership: 107.84% [Q3] → 108.61% (+0.77%) [Q4]

1% less capital invested

Capital invested by funds: $3.3B [Q3] → $3.26B (-$48.6M) [Q4]

33% less funds holding in top 10

Funds holding in top 10: 9 [Q3] → 6 (-3) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $43 6% upside
• Avg. target: $50 23% upside
• High target: $61 51% upside

4 analyst ratings

• positive: 2 50%
• neutral: 2 50%
• negative: 0 0%

RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target	51% upside $61	Outperform Maintained	13 Feb 2025
UBS John Sourbeer 20% 1-year accuracy 1 / 5 met price target	11% upside $45	Neutral Maintained	13 Feb 2025
Citigroup Patrick Donnelly 33% 1-year accuracy 10 / 30 met price target	24% upside $50	Buy Upgraded	11 Dec 2024
Jefferies Tycho Peterson 47% 1-year accuracy 7 / 15 met price target	6% upside $43	Hold Initiated	10 Dec 2024